Pulsenmore Ltd (PLSM) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of and for the year 2025, average high and low, overall ranking from Dec 31 2025 to - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pulsenmore Ltd   (PLSM)


Pulsenmore Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pulsenmore Ltd's ROI in the fourth quarter of 2025?
Pulsenmore Ltd achieved a return on average invested assets (ROI) of 17.42 % in its fourth quarter of 2025, this is above PLSM's average return on investment of 0%.
Pulsenmore Ltd invested over the 12 months ending in its fourth quarter of 2025 $29 million

ROI has improved compared to 0% in the third quarter of 2025, due to net income growth.

Within the Healthcare sector Pulsenmore Ltd achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the third quarter of 2025 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Investment Change TTM 194.39 % - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 28 29 29 29 39
Return On Investment (TTM) 17.42 % 0 % 0 % 0 % 0 %
PLSM's Overall Ranking # # # # #
Seq. Investment Change TTM -8.57 % 29.84 % 42.53 % 74 % -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 5 0 0 0 0

PLSM Company Profile >> Back to PLSM Roi Comparisons >> See Annual PLSM Return On Investment



Return On Investment PLSM's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Pulsenmore Ltd's IV. Quarter Investments $ 28 Millions PLSM's Balance sheet
Pulsenmore Ltd's IV. Quarter Income $ 5 Millions Quarterly PLSM's Income Statement
PLSM's Income by Division See PLSM's Income by Division


PLSM Annual Return On Investment (Dec 31 2025)
2025



Total Investments in Millions 29 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -5 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -17.32 % - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PLSM's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PLSM's Competitors
Subscribers only: Roi for Pulsenmore Ltd's Suppliers
Subscribers only: Return On Investment for PLSM's Customers

Other Ratios
PLSM's Roa PLSM's Inventory Turnover Ratio PLSM's Growth Rates PLSM's Dividend Statistics
PLSM's Profitability Ratios PLSM's Asset Turnover Ratio PLSM's Dividend Growth
PLSM's Roe PLSM's Valuation Ratios PLSM's Financial Strength Ratios PLSM's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Theravance Biopharma inc   46.03 %
Elite Pharmaceuticals Inc   45.80 %
Enlivex Therapeutics Ltd  45.75 %
Gsk Plc  44.94 %
Galmed Pharmaceuticals Ltd   43.72 %
Abeona Therapeutics Inc   42.25 %
Alpha Tau Medical Ltd  42.04 %
Dariohealth Corp   41.31 %
Acadia Pharmaceuticals Inc   39.64 %
Medinotec Inc   37.45 %
Zevra Therapeutics Inc   36.78 %
Oramed Pharmaceuticals Inc  35.86 %
Ptc Therapeutics inc   35.12 %
Mettler toledo International Inc   34.74 %
Newgenivf Group Limited  32.05 %
Eli Lilly And Company  31.62 %
Indivior Pharmaceuticals Inc   31.00 %
Hutchmed china Limited  30.87 %
Medpace Holdings Inc   30.44 %
Adma Biologics Inc   28.75 %
Carlisle Companies Incorporated  27.24 %
Incyte Corporation  27.08 %
Vaxart Inc   26.63 %
Compugen Ltd  26.32 %
Arrowhead Pharmaceuticals Inc   25.56 %
Puma Biotechnology Inc   25.39 %
Catalyst Pharmaceuticals Inc   24.25 %
Iradimed Corporation  22.97 %
Innoviva Inc   22.62 %
Illumina Inc   22.37 %

Date modified: 2026-09-08T15:11:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.